The research will be carried out in Sakarya University Training and Research Hospital
Endocrinology Polyclinic. It is planned to include a total of 80 patients in the research (40
patients in the control group - 40 patients in the experiment group). The first step of this
study is to develop the scales to be used in the study. The Hypothyroidism Symptom Management
Scale and the Hypothyroidism Symptom Severity Scale will be developed. In the second stage,
data will be collected. The Patient Information Form, Hypothyroidism Symptom Severity Scale,
and Hypothyroidism Symptom Management Scale will be applied to the experimental group that
meets the research criteria and agrees to participate. The patient's blood test findings
(TSH, T3, T4, Anti-Tg, Anti TPO, Antithyroglobulin, Hmg, Hct) will also be recorded at the
first meeting. The researcher will measure the patient's height, weight, and vital signs. The
mobile application will be introduced to the patients and downloaded to the patient's phones,
and a username and password will be created. The content of this mobile application;
Interventions will be planned based on evidence-based practices to alleviate or reduce the
symptoms of hypothyroidism. These initiatives are planned both in written form and in short
video narration. Patients will be asked to watch the videos in the mobile application for the
first week. At the end of each week, patients will be asked to report symptoms in the
application and read and follow the recommendations for the relevant symptom. The usage
period of the mobile application is determined as three months (12 weeks). In addition, at
the end of the fourth week, patients will be followed up by having the symptom management
scale and symptom severity scale applied via the mobile application. In the 6th and 12th
weeks, evaluations of the patient's laboratory test results, vital signs, height, and weight
measurements, will also be evaluated besides the scales. In the first interview with the
individuals in the control group, after explanations are made about the research and their
verbal and written consents are accordingly obtained, First, the Patient Information Form,
the Hypothyroidism Symptom Severity Scale, and the Hypothyroidism Symptom Management Scale
will be administered as a pre-test. At the first interview, the patient's blood test
findings, height, weight, and vital signs will be recorded. Measurements will be repeated
when individuals come to their outpatient clinic appointments 6 and 12 weeks after the first
interview.
